Cybin (HELP) FCF Margin (2020 - 2024)

Cybin (HELP) reported FCF Margin of 130.64% for Q4 2024, down 91836.0% on a YoY basis from N/an in Q1 2024, and down 116.58% quarter-over-quarter from 787.72% in Q4 2023.

Cybin (HELP) FCF Margin (2020 - 2024) Analysis & Trends

Cybin has reported FCF Margin for 3 years, with the latest figure at 130.64% in Q4 2024.

  • For the quarter ending Q4 2024, FCF Margin fell 91836.0% year-over-year to 130.64%; the trailing twelve-month figure through Dec 2024 stood at 564.09% (changed N/A YoY), and the FY2021 full-year result was 2217.82%, changed N/A from the prior year.
  • FCF Margin for Q4 2024 stood at 130.64%, down from 787.72% in the prior quarter.
  • The five-year high for FCF Margin was 787.72% in Q4 2023, with the low at 185.65% in Q2 2020.
  • Historically, FCF Margin has averaged 157.14% across 3 years, with a median of 130.64% in 2024.
  • The largest YoY upside for FCF Margin was 91836 bps in 2024 against a maximum downside of 91836 bps in 2024.
  • Cybin's FCF Margin stood at 185.65% in 2020, then soared by 524 bps to 787.72% in 2023, then tumbled by 117 bps to 130.64% in 2024.
  • The last three FCF Margin figures came in at 130.64% (Q4 2024), 787.72% (Q4 2023), and 185.65% (Q2 2020), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -130.64%
Dec 31, 2023 787.72%
Jun 30, 2020 -185.65%